Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00967889
What this trial is testing

Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Cancer Research UK
Testing effectiveness (Phase 2)Study completedNCT00004043
What this trial is testing

Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 25
Not applicableStudy completedNCT00002924
What this trial is testing

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 184
Early research (Phase 1)Study completedNCT00002677
What this trial is testing

Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors

Who this might be right for
Prostate CancerUnspecified Adult Solid Tumor, Protocol Specific
University of Maryland, Baltimore 24
Not applicableUnknownNCT04983628
What this trial is testing

Molecular Profiling in Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticProstate Cancer RecurrentGermline BRCA1 Gene Mutation+2 more
Hellenic Cooperative Oncology Group 250
Testing effectiveness (Phase 2)Study completedNCT03315871
What this trial is testing

Combination Immunotherapy in Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00058253
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Recurrent Prostate CancerStage IV Prostate CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Ended earlyNCT00005072
What this trial is testing

Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Vical 25
Testing effectiveness (Phase 2)Study completedNCT00278070
What this trial is testing

Metronomic Oral Vinorelbine in Patients With Metastatic Tumors

Who this might be right for
Breast CancerNon Small Cell Lung CancerProstate Cancer
Hellenic Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT06907641
What this trial is testing

Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the Detection of Prostate Cancer Recurrence in the Setting of Biochemical Failure Following Radical Prostatectomy

Who this might be right for
Prostate Cancer (Post Prostatectomy)
St Vincent's Hospital, Sydney 50
Testing effectiveness (Phase 2)UnknownNCT02935205
What this trial is testing

Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
Mamta Parikh 38
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Not applicableLooking for participantsNCT06982469
What this trial is testing

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

Who this might be right for
Prostate CancerProstatectomyLocal Recurrence of Malignant Tumor of Prostate+2 more
Clinica Universidad de Navarra, Universidad de Navarra 20
Testing effectiveness (Phase 2)Looking for participantsNCT05946824
What this trial is testing

This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.

Who this might be right for
Recurrent Prostate Cancer After Surgery
University of Rochester 80
Not applicableEnded earlyNCT00244894
What this trial is testing

Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer

Who this might be right for
FatigueHot FlashesProstate Cancer
OHSU Knight Cancer Institute 22
Testing effectiveness (Phase 2)Study completedNCT01075308
What this trial is testing

SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 32
Early research (Phase 1)Study completedNCT00003391
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 30
Not applicableStudy completedNCT00483678
What this trial is testing

Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners

Who this might be right for
Prostate CancerPsychosocial Effects of Cancer and Its TreatmentSexual Dysfunction+1 more
Memorial Sloan Kettering Cancer Center 64
Testing effectiveness (Phase 2)Study completedNCT00390468
What this trial is testing

Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerPainProstate Cancer
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT04733768
What this trial is testing

18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Alberta 100
Next Page